Cholesterol Supplement can Alleviate the Severity of Pulmonary Infection of Patients with Hypocholesterolemia

Jia Wang¹ and Zhong-xin Hong^1,

¹Department of Clinical Nutrition, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Cite this paper:
Jia Wang and Zhong-xin Hong. Cholesterol Supplement can Alleviate the Severity of Pulmonary Infection of Patients with Hypocholesterolemia. Journal of Food and Nutrition Research. 2016; 4(3):131-136. doi: 10.12691/jfnr-4-3-1

Abstract

Background: Decreased concentrations of total cholesterol concentration could occur in the course of some illness, especially the infection illness. Low cholesterol concentration has been associated clinically with several adverse outcomes. We conducted a study to supplement cholesterol, and observe the change on the test indexes and the severity of disease. We then further discussed the relationships among the supplementation on cholesterol and pro- and anti- inflammatory cytokines. Methods: A randomized and controlled clinical trial was conducted at the infectious disease department in Beijing Friendship Hospital，Capital Medical University，Beijing. Between January 2011 and December 2012, all hospitalized patients with pulmonary infection were invited. The patients were assigned into intervention group and control group randomly. After 10-day supplementation and observation, we analyzed the changes of clinical measurements. Results: In the intervention group, there were statistically significant increases in concentration of total cholesterol (TC), albumin (ALB), pre albumin ( PA) after 10-day intervention of cholesterol supplementation (P<0.05). The concentration of C reactive protein (CRP), interleukin-6 (IL-6), and the severity of disease by Simplified Acute Physiology Score II (SAPSII) assessment after intervention were significant lower than those before intervention (P<0.05). The concentration of interleukin-10 (IL-10) increased in a trend (P=0.074), but had no significant difference. In the control group, the data showed that TC, PA and CRP had changes in trend after 10-day observation (P<0.1), but the changes had no significance (P>0.05). Compared the differences on indexes between after 10-day intervention in intervention group and after 10-day observation in control group, the compared data showed that there were significant differences in seven indexes, TC, Body Mass Index (BMI), ALB, PA, CRP, IL-6 and the severity of disease (P<0.05). The increased concentrations of TC, ALB and PA in intervention group were more than those changes in control group. The BMI in intervention group was increased more than that in control group. The decreased concentrations of CRP and IL-6 in intervention group were more than those changes in control group. The improvement of severity of disease in intervention group was more obvious than that in control group. The improvement of nutrition status in intervention group was significant. Conclusion: Infectious disease, especially pneumonia and pulmonary infection disease, can lead to hypocholesterolemia. Supplementation of cholesterol properly can improve the nutritional status, decrease the severity of disease, and improve the prognosis of disease.

Keywords:
hypocholesterolemia pulmonary infection nutritional status severity of disease

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Xue H, Li JS. Hypocholesterolemia appears negatively a prognostic parameter. Parenteral and Enteral Nutrition, 2004, 11 (6): 380-381.
[2]	Hong ZX, Wang J, Liu ZH, et al. Low plasma total cholesterol concentration: may be related to malnourished hospitalized patients. Chinese Journal of clinical nutrition, 2009, 17(5):290-293.
[3]	Gordon BR, Parker TS, Levine DM, et al. Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med, 2001,29: 1563-1558.
[4]	Gordon BR, Parker TS, Levine DM, et al. Low lipid concentrations in critical illness: Implications for preventing and treating endotoxemia. Crit Care Med, 1996, 24: 584-589.
[5]	Diederich W, Orso E, Dronik W, Schmitz G. Apolipoprotein A1 and HDL3 inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC 42. Atherosclerosis, 2001, 159:313-324.
[6]	Ruan XZ, Varghese Z, Powers SH, Moorhead JF. Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation. Kidney Int, 2001, 60: 2037-2038.
[7]	de Beer FC, Connell PM, Yu J, et al. HDL modification by secreting phospholipase A2 promotes scavenger receptor class B type 1 interaction and accelerates HDL catabolism. J Lipid Res, 2000, 41: 1849-1857.
[8]	Leonarduzzi G, Arkaw MC, Basaga H, et al. Lipid oxidation products in cell signaling. Free Radic Biol Med, 2000, 28: 1370-1378.
[9]	Buechler C, Ritter M, Quoc CD, et al. Lipopolysaccharide inhibits the expression of the scavenger receptor Cla-1 in human monocytes and macrophages. Biochem Biophys Res Commun, 1999, 262: 251-254.
[10]	Gierens H, Nauck M, Roth M, et al. Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements. Atheroscler Thromb Vasc Biol, 2000, 20: 1777-1783.
[11]	Roth G, Kotzka J, Kremer L, et al. MAP kinases Erk1/2 phosphorylate sterol regulatory binding-element protein (SREBP)-1a at serine 117 in vitro. J Biol Chem, 2000. 275: 33302-33307.
[12]	Muldoon MF, Marsland A, Flory JD, et al. Immune system differences in men with hypo- and hypercholesterolemia. Clin Immuno Immunopathol, 1997, 84 (2): 145-149.
[13]	Delgado-Rodriguez M, Medina-Cuadros M, Martinez-Gallego G, Sillero-Arenas M. Total cholesterol, HDL-cholesterol, and risk of nosocomial infection: A prospective study in surgical patients. Infect Control Hosp Epidemiol, 1997, 18: 6-8.
[14]	Dunham CM, Fealk MH, Sever WE. Following severe injury, hypocholesterolemia improves with convalescence but persists with organ failure or onset of infection. Crit Care, 2003, 7, R145-R153.
[15]	Giovannini I, Boldrini G, Chiarla C, et al. Pathophysiologic correlates of hypocholesterolemia in critically ill surgical patients. Intensive Care Medicine, 1999, 25 (7): 748-751.
[16]	Liu X. Preliminary study on hypocholesterolemia for the aged people above sixty. Chinese General Practice, 2003, 6(4): 291-292.
[17]	Rodriguez Reguero JJ, Iglesias Cubero G, Vasquez M, et al. Variation in plasma lipid and lipoprotein concentrations in community-acquired pneumonia: A six month prospective study. Eur J Clin Chem Clin Biochem, 1996, 34: 245-249.
[18]	Bonville DA, Parker TS, Levine DM, et al. The relationships of hypocholesterolemia to cytokine concentrations and mortality in critically ill patients with systemic inflammatory response syndrome. Surg Infect, 2004, 5(1): 39-49.
[19]	Nie H, Huang XK, Lian Y, et al. Relationship between hypocholesterolemia and the prognosis of severe multiple injury. Chinese Journal of critical care medicine, 2007, 27(7): 577-579.
[20]	Fraunberger P, Schaefer S, Werdan K, et al. Reduction of circulating cholesterol and apoliprotein levels during sepsis. Clin Chem Lab Med, 1999, 37: 357-362.
[21]	Memon RA, Staprans I, Noor M, et al. Infection and inflammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol, 2000, 20: 1536-1542.
[22]	Ettinger WH, Varma VK, Sorci-Tjomas M, et al. Cytokines decrease apolipoprotein accumulation in medium from HEP G2 cells. Arterioscler Thromb, 1994, 14:8-13.
[23]	Barbosa-Silva MC, Barros AJ. Indications and limitations of the use of subjective global assessment in clinical practice: an update. Curr Opin Clin Nutr Metab Care, 2006, 9(3): 263-269．
[24]	Hong ZX, Hua X, Wu l, et al. The investigation and analysis of Hypocholesterolemia in Hospitalized Patient. Chinese Journal of clinical nutrition, 2008, 16(1): 22-25.